Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis

Effects of incretin-based therapies on neurocognitive function in humans: A systematic review of the literature

(2018) Jonathan L. Dumbrill et al.   Primary Care Diabetes

Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease

(2018) Amy Claxton et al.   JOURNAL OF ALZHEIMERS DISEASE

Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes

(2018) Tze Pin Ng et al.   JOURNAL OF ALZHEIMERS DISEASE

Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia

(2016) Hiroyuki Umegaki   DRUGS & AGING

Peroxisome Proliferator-Activated Receptor-Gamma Agonists for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

(2014) Jia Liu et al.   DRUGS & AGING

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis

(2014) Mengying Liu et al.   Scientific Reports

Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin

(2013) E. M. Moore et al.   DIABETES CARE

Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art

(2013) Suzanne M de la Monte   Expert Opinion on Drug Delivery

Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study

(2012) Patrick Imfeld et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Mitochondrial diseases

(2012) Anthony HV Schapira   LANCET

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

(2011) Suzanne Craft   ARCHIVES OF NEUROLOGY

Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry

(2008) Jaime L. Peters et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY